InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Discover the complete record of transactions filed by Gosebruch Henry O, Director. Officer active across 1 companies, notably AbbVie Inc.. Cumulatively, 8 filings have been recorded. Total volume traded: €4.1m. The latest transaction was filed on 1 March 2022 — Cession. Regulator: SEC (Form 4). All data is openly available.
Declarations8 total
€2m15,733 shares@ €130.89480.0006% mcap12.1% of flow
Common Stock, $0.01 par value
SEC:0001179110-22-003107:0·
€4m83,960 shares@ €52.55310.0012% mcap26.0% of flow
Common Stock, $0.01 par value
SEC:0001179110-22-003108:0·
€4m83,960 shares@ €52.55310.0012% mcap26.0% of flow
Common Stock, $0.01 par value
SEC:0001179110-22-003076:0·
€2m15,733 shares@ €130.89480.0006% mcap12.1% of flow
Common Stock, $0.01 par value
SEC:0001179110-22-001923:0·
€4m30,156 shares@ €133.62890.0011% mcap23.7% of flow
Common Stock, $0.01 par value
SEC:0001179110-22-001841:0·
036,673 shares0
Common Stock, $0.01 par value
SEC:0001179110-22-001513:0·
030,000 shares0
Common Stock, $0.01 par value
SEC:0001179110-21-008720·
030,000 shares0
Common Stock, $0.01 par value
SEC:0001179110-21-008720:0·
8 of 8 declarations
About Gosebruch Henry O
Henry O. Gosebruch is EVP and Chief Strategy Officer at AbbVie Inc. He oversees the company's strategy and contributes to strategic planning. His role is essential in ensuring growth and innovation at AbbVie.
